Clinical Trials Directory

Trials / Completed

CompletedNCT06054945

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block

Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block in Knee Arthroplasty Patients Under Spinal Anesthesia: A Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
88 (actual)
Sponsor
Samsun University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In our clinic, routine suprainguinal fascia iliaca block (SIFIB) has been administered for postoperative analgesia in patients undergoing knee arthroplasty. Recently, we have introduced the IPACK (Infiltration between the Popliteal Artery and Capsule of the Knee) block to this regimen, and the aim of this retrospective study is to determine whether the addition of the IPACK block enhances the quality of analgesia. Knee arthroplasty, also known as knee joint replacement surgery, is a common procedure performed to alleviate pain and improve joint function in patients with knee osteoarthritis or other knee-related conditions. Postoperative pain management is crucial for patient comfort and overall recovery. In this study, we aimed to compare the two techniques mentioned earlier, namely the SIFIB (Suprainguinal Fascia Iliaca Block) and the SIFIB+IPACK, by examining the data of patients who underwent knee arthroplasty under spinal anesthesia at our clinic between January 1, 2023, and September 1, 2023.

Conditions

Interventions

TypeNameDescription
PROCEDURESIFIB (suprainguinal fascia iliaca block)Ultrasound guided Suprainguinal Fascia Iliaca Block for Knee Arthroplasty Patients
OTHERIPACK (Interspace between the popliteal artery and capsule of the posterior knee )Ultrasound guided IPACK (Interspace between the popliteal artery and capsule of the posterior knee ) Block for Knee Arthroplasty Patients
DEVICEPatient controlled anagesia deviceThose who were administered opioids with PCA as rescue analgesic in the postoperative analgesia plan on the selected dates will be included in the study.

Timeline

Start date
2023-09-03
Primary completion
2023-09-15
Completion
2023-09-15
First posted
2023-09-26
Last updated
2023-09-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06054945. Inclusion in this directory is not an endorsement.